Bids Are Invited For Annual Acquisition 2025/2026 Of Injectable General Medicines Group 03

Annual Acquisition 2025/2026 Of Injectable General Medicines Group 03. Tranexamic Acid, Adenosine, Human Albumin, Alfaepoetin, Pulmonary Surfactant, Pulmonary Surfactant, Alpostadil, Alpostadil, Alteplase, Aminophylline, Amiodarone, Atropine Sulfate, Betamethasone, Bromopride, Caffeine, Ferric Carboxymosis, Ketoprofen, Clonidinine Hydrochloride, Sodium Dantrolene, Delanoside, Dexamethasone, Diclofenac, Diphenylorderum Hydrochloride, Sodium Dipyrone, Dopamine, Dopamine, Pamily, Enoxaparin, Enoxaparin, Enoxaparin, Enoxaparin, Epinephrine, Butthylbromide Scopolamine, Smolol Roller, Ethylephrine, Ethylephin Hydrochloride, Filgrastim, Phytomenadione, Furosemide, Sodium Heparin, Sodium Heparin, Hyaluronidase, Hydralazine, Hydrocortisone, Hydrocortisone, Human Immunoglobulin, Human Immunoglobulin, Insulin, Insulin, Insulin, Insulin, Insulin, Metilergometrical Maleate, Methylprednisolone, Methylprednisolone, Metoclopramide Hydrochloride, Metoprolol, Milhrinone, Ethanolamine Oleato, Nitroglycerin, Nitrogruseto Of Sodium, Norepinephrine, Oxytocin, Trace Elements, Omeprazole, Wavenseronron Hydrochloride, Pantoprazole, Polydocanol, Polydocanol, Polydocanol, B -Complex Vitamins, Multivitamines, Promise Hydrochloride, Protamine Hydrochloride, Iron Iii, Salbutamol, Tenoxicam, Terometamol, Vasopressin, Tiamine, Cyanocobalamine, Ascorbic Acid